Babson, BD Partnership to Advance Diagnostic Blood Collection in New Care Settings
Babson Diagnostics and BD announced the expansion of a strategic partnership to move blood sample collection into new care settings.
Read MorePosted by Andy Lundin | May 12, 2022 | Specimen Collection & Handling |
Babson Diagnostics and BD announced the expansion of a strategic partnership to move blood sample collection into new care settings.
Read MorePosted by Chris Wolski | May 12, 2022 | Sepsis |
Improving outcomes with sepsis is dependent on timely diagnosis and treatment. Culture-independent testing is one way to save time.
Read MorePosted by Chris Wolski | May 11, 2022 | Lab Management |
Laboratory leadership needs to develop coherent succession planning to allow for the continuity of laboratory operations.
Read MorePosted by Andy Lundin | Apr 28, 2022 | Anatomic Pathology, Company News |
Avista Capital Partners, a private equity firm focused on healthcare, closed on the sale of pathology laboratory Inform Diagnostics to Fulgent Genetics.
Read MorePosted by Andy Lundin | Apr 14, 2022 | Sexually Transmitted Diseases, Standards |
Few online STI test services in the U.K. meet national recommended standards, with independent sector providers least likely to be compliant.
Read More